{"id":"W2742165495","doi":"","title":"Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: Results of a randomised placebo-controlled trial (ABILITY-1)","year":2013,"lang":"en","type":"article","venue":"QUT ePrints (Queensland University of Technology)","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Cilag; Procter and Gamble; Chugai Pharmaceutical; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Sanofi; Abbott Laboratories","keywords":"Adalimumab; Medicine; BASDAI; Ankylosing spondylitis; Placebo; Spondylitis; Internal medicine; Clinical endpoint; Visual analogue scale; Physical therapy; Randomized controlled trial; Arthritis; Disease; Psoriatic arthritis; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002164173,0.0001990804,0.001180995,0.0006309454,0.00006462086,0.000002198482,0.0001335931,0.000228702,0.00005636715],"category_scores_gemma":[0.0002083431,0.0001695845,0.0001490341,0.0004605422,0.0006836216,0.00006835646,0.0001100544,0.0001939245,0.000002517562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003998528,"about_ca_system_score_gemma":0.00006277089,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007144924,"about_ca_topic_score_gemma":0.0002063065,"domain_scores_codex":[0.9986091,0.0000594239,0.000503363,0.0003667915,0.000226414,0.0002349288],"domain_scores_gemma":[0.9987358,0.0001668593,0.0003719154,0.0004128714,0.000241481,0.00007103261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7613846,0.00115955,0.2310611,0.00005127465,0.0004441667,0.00002680293,0.0002242671,0.00000221222,0.0001248119,0.00003433374,0.00002223016,0.005464706],"study_design_scores_gemma":[0.5904629,0.002214574,0.4064108,0.0002365258,0.0001551483,0.00000225814,0.0002135961,0.000006350841,0.0001208665,0.00004729192,0.00004854453,0.00008107615],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938775,0.000109672,0.00001022947,0.000282476,0.00003795698,0.004724216,0.00005601555,0.00003064519,0.0008712808],"genre_scores_gemma":[0.9989048,0.0002262485,0.0007714003,0.000003200377,0.000006178956,0.00001067121,0.00001867007,0.0000095913,0.00004924672],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1753498,"threshold_uncertainty_score":0.6915454,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003545603562280225,"score_gpt":0.1861699903924091,"score_spread":0.1826243868301288,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}